Editorial Comment.

Abstract

No AccessJournal of UrologyAdult Urology1 Aug 2022Editorial CommentThis article comments on the following:Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer E. David Crawford E. David CrawfordE. David Crawford Department of Urology, University of California San Diego, La Jolla, California More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002676.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 208(2), p. 324 Reference 1. : Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group trial 9346 (INT-0162). J Clin Oncol 2006; 24: 3984. Google Scholar © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyMar 28, 2022, 12:00:00 AMAbsolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer Volume 208Issue 2August 2022Page: 324-324 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information E. David Crawford Department of Urology, University of California San Diego, La Jolla, California More articles by this author Expand All Advertisement PDF DownloadLoading ...